Ventyx Biosciences, Inc.

Ownership Transactions Reported by 21 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+630K	94.6%	$2.00	+$1.26M
Sells	1	-36.2K	5.4%	$2.25	-$81.5K
Net	+1	+594K	89.1%		+$1.18M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
NSV Partners III LP	10%+ Owner	$373M			Jun 24, 2024
NSV Investments I, L.P.	10%+ Owner	$35.8M			Oct 25, 2021
venBio Global Strategic Fund III, L.P.	Other*, 10%+ Owner	$10.6M			Jun 9, 2022
Somu Subramaniam	Director	$9.52M			Mar 28, 2025
Raju Mohan	CEO AND PRESIDENT, Director	$5.49M	+$960K	+21.2%	Mar 28, 2025
Cormorant Asset Management, LP	Former 10% Owner	$2.99M			Oct 25, 2021
Christopher Krueger	Chief Business Officer	$1.61M			Apr 2, 2024
William J. Sandborn	President and Chief Medical Officer	$754K			Aug 31, 2023
John Nuss	Chief Scientific Officer	$521K	-$81.5K	-13.5%	Apr 2, 2025
Sheila Gujrathi	Director	$301K	+$301K		Dec 23, 2024
Martin Auster	Chief Financial Officer	$205K			Apr 2, 2024
Roy Gonzales	Senior VP, Finance	$4.02K			Jan 2, 2025
Aaron Royston	Director				Jun 9, 2022
Allison Hulme	Director				Jun 6, 2024
Jorn Drappa	Chief Medical Officer				Feb 4, 2022
Mark S. Forman	Chief Medical Officer				Jan 2, 2025
Onaiza Cadoret-Manier	Director				Jun 6, 2024
Jigar Choksey	Director				Jun 9, 2022
Matthew Richard Moore	Chief Operating Officer				Jan 2, 2025
Richard Gaster	Director				Jun 9, 2022
William Richard White	Director				Jun 6, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.